Article
A Novel Immune‑Related Gene-Based Model: Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
2022-05-12
Abstract excerpt
<h4>Background: </h4> Liver hepatocellular carcinoma (LIHC) remains a significant global health challenge. Immunotherapy for LIHC is a very promising treatment modality. However, some patients with LIHC have a poor response to tumor immunotherapy. Thus, it is imperative to fully understand liver cancer immune subtypes, by which individualized and optimized immunotherapy would be developed. <h4>Methods: </h4>: We d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b715c666-ab41-5aa1-969e-fd5993e57015
- DOI
- 10.21203/rs.3.rs-1630689/v1
